These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 18666888)
1. Osteoclast differentiation and function in aquaglyceroporin AQP9-null mice. Liu Y; Song L; Wang Y; Rojek A; Nielsen S; Agre P; Carbrey JM Biol Cell; 2009 Mar; 101(3):133-40. PubMed ID: 18666888 [TBL] [Abstract][Full Text] [Related]
2. Involvement of aquaporin 9 in osteoclast differentiation. Aharon R; Bar-Shavit Z J Biol Chem; 2006 Jul; 281(28):19305-9. PubMed ID: 16698796 [TBL] [Abstract][Full Text] [Related]
3. Deletion of Adseverin in Osteoclasts Affects Cell Structure But Not Bone Metabolism. Cao Y; Wang Y; Sprangers S; Picavet DI; Glogauer M; McCulloch CA; Everts V Calcif Tissue Int; 2017 Aug; 101(2):207-216. PubMed ID: 28389691 [TBL] [Abstract][Full Text] [Related]
4. Ablation of Stabilin-1 Enhances Bone-Resorbing Activity in Osteoclasts In Vitro. Kim SY; Lee EH; Park SY; Choi H; Koh JT; Park EK; Kim IS; Kim JE Calcif Tissue Int; 2019 Aug; 105(2):205-214. PubMed ID: 31025051 [TBL] [Abstract][Full Text] [Related]
5. Studies of OC-STAMP in Osteoclast Fusion: A New Knockout Mouse Model, Rescue of Cell Fusion, and Transmembrane Topology. Witwicka H; Hwang SY; Reyes-Gutierrez P; Jia H; Odgren PE; Donahue LR; Birnbaum MJ; Odgren PR PLoS One; 2015; 10(6):e0128275. PubMed ID: 26042409 [TBL] [Abstract][Full Text] [Related]
6. Role of cell-matrix interactions in osteoclast differentiation. McHugh KP; Shen Z; Crotti TN; Flannery MR; Fajardo R; Bierbaum BE; Goldring SR Adv Exp Med Biol; 2007; 602():107-11. PubMed ID: 17966395 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of osteoclast differentiation and collagen antibody-induced arthritis by CTHRC1. Jin YR; Stohn JP; Wang Q; Nagano K; Baron R; Bouxsein ML; Rosen CJ; Adarichev VA; Lindner V Bone; 2017 Apr; 97():153-167. PubMed ID: 28115279 [TBL] [Abstract][Full Text] [Related]
8. Deficiency in the phosphatase PHLPP1 suppresses osteoclast-mediated bone resorption and enhances bone formation in mice. Mattson AM; Begun DL; Molstad DHH; Meyer MA; Oursler MJ; Westendorf JJ; Bradley EW J Biol Chem; 2019 Aug; 294(31):11772-11784. PubMed ID: 31189651 [TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts. Takeshita S; Kaji K; Kudo A J Bone Miner Res; 2000 Aug; 15(8):1477-88. PubMed ID: 10934646 [TBL] [Abstract][Full Text] [Related]
10. RARγ is a negative regulator of osteoclastogenesis. Green AC; Poulton IJ; Vrahnas C; Häusler KD; Walkley CR; Wu JY; Martin TJ; Gillespie MT; Chandraratna RA; Quinn JM; Sims NA; Purton LE J Steroid Biochem Mol Biol; 2015 Jun; 150():46-53. PubMed ID: 25800721 [TBL] [Abstract][Full Text] [Related]
11. Regulation of osteoclast differentiation and function by phosphate: potential role of osteoclasts in the skeletal abnormalities in hypophosphatemic conditions. Hayashibara T; Hiraga T; Sugita A; Wang L; Hata K; Ooshima T; Yoneda T J Bone Miner Res; 2007 Nov; 22(11):1743-51. PubMed ID: 17638577 [TBL] [Abstract][Full Text] [Related]
12. Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts. Kneissel M; Luong-Nguyen NH; Baptist M; Cortesi R; Zumstein-Mecker S; Kossida S; O'Reilly T; Lane H; Susa M Bone; 2004 Nov; 35(5):1144-56. PubMed ID: 15542040 [TBL] [Abstract][Full Text] [Related]
13. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity. Kanatani M; Sugimoto T; Kano J; Kanzawa M; Chihara K J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054 [TBL] [Abstract][Full Text] [Related]
14. Cyclic Dinucleotides Inhibit Osteoclast Differentiation Through STING-Mediated Interferon-β Signaling. Kwon Y; Park OJ; Kim J; Cho JH; Yun CH; Han SH J Bone Miner Res; 2019 Jul; 34(7):1366-1375. PubMed ID: 30779854 [TBL] [Abstract][Full Text] [Related]
15. Novel antiosteoclastogenic activity of phloretin antagonizing RANKL-induced osteoclast differentiation of murine macrophages. Kim JL; Kang MK; Gong JH; Park SH; Han SY; Kang YH Mol Nutr Food Res; 2012 Aug; 56(8):1223-33. PubMed ID: 22700286 [TBL] [Abstract][Full Text] [Related]
16. Biophysical assessment of aquaporin-9 as principal facilitative pathway in mouse liver import of glucogenetic glycerol. Calamita G; Gena P; Ferri D; Rosito A; Rojek A; Nielsen S; Marinelli RA; Frühbeck G; Svelto M Biol Cell; 2012 Jun; 104(6):342-51. PubMed ID: 22316404 [TBL] [Abstract][Full Text] [Related]
18. RANKL coordinates cell cycle withdrawal and differentiation in osteoclasts through the cyclin-dependent kinase inhibitors p27KIP1 and p21CIP1. Sankar U; Patel K; Rosol TJ; Ostrowski MC J Bone Miner Res; 2004 Aug; 19(8):1339-48. PubMed ID: 15231022 [TBL] [Abstract][Full Text] [Related]
19. Aqp9 Gene Deletion Enhances Retinal Ganglion Cell (RGC) Death and Dysfunction Induced by Optic Nerve Crush: Evidence that Aquaporin 9 Acts as an Astrocyte-to-Neuron Lactate Shuttle in Concert with Monocarboxylate Transporters To Support RGC Function and Survival. Mori S; Kurimoto T; Miki A; Maeda H; Kusuhara S; Nakamura M Mol Neurobiol; 2020 Nov; 57(11):4530-4548. PubMed ID: 32748371 [TBL] [Abstract][Full Text] [Related]
20. The Macrophage-Osteoclast Axis in Osteoimmunity and Osteo-Related Diseases. Yao Y; Cai X; Ren F; Ye Y; Wang F; Zheng C; Qian Y; Zhang M Front Immunol; 2021; 12():664871. PubMed ID: 33868316 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]